GlaxoSmithKline PLC Annual Report 2014 on Form 20-F (1809G)
March 02 2015 - 8:30AM
UK Regulatory
TIDMGSK
RNS Number : 1809G
GlaxoSmithKline PLC
02 March 2015
GlaxoSmithKline plc
Annual Report 2014 on Form 20-F
In accordance with Section 203.01 of the New York Stock Exchange
Listed Company Manual, GlaxoSmithKline plc ("GSK") announces that
on 27 February 2015 it filed with the Securities and Exchange
Commission an Annual Report on Form 20-F that included audited
financial statements for the year ended 31 December 2014. GSK's
Annual Report 2014 on Form 20-F is available online at GSK's
website at www.gsk.com/corporatereporting and also online at
www.sec.gov.
Ordinary Shareholders may also elect to receive notification by
email of the publication of financial reports by registering on
www.shareview.co.uk.
A hard copy version of the Annual Report 2014, together with the
Annual Summary and Notice of Annual General Meeting will be
available on or about 25 March 2015
Shareholders have the ability to receive, upon request, a hard
copy version of GSK's complete audited financial statements for the
year ended 31 December 2014, free of charge, by either:
(i) writing to Equiniti, our registrars in the UK, at the
following address: Equiniti, Aspect House, Spencer Road, Lancing,
West Sussex BN99 6DA, or by telephone on 0871 384 2991 (inside the
UK) or +44 (0)121 415 7067 (outside the UK);
(ii) writing to The Bank of New York Mellon, our ADR depositary
in the US, at the following address: BNY Mellon Depositary
Receipts, PO Box 30170, College Station, Texas, TX 77842-3170, or
by telephone on 1877 3531154 (US toll free); or
(iii) contacting the GSK Response Center in the USA at 1888-825-5249 (US toll free).
Victoria Whyte
Company Secretary
2 March 2015
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or
projections made by GSK, including those made in this announcement,
are subject to risks and uncertainties that may cause actual
results to differ materially from those projected. Such factors
include, but are not limited to, those described under Item 3.D
'Risk factors' in the company's Annual Report on Form 20-F for
2014.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSJTMFTMBIMMRA
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024